title: The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat.
abstract: Parkinson's disease (PD) is a common progressive neurodegenerative disorder, for which at present no causal treatment is available. On the understanding that the causes of PD are mainly oxidative stress and mitochondrial dysfunction, antioxidants and other drugs are expected to be used. In the present study, we demonstrated for the first time that pure polyphenols such as gallic acid, ferulic acid, caffeic acid, coumaric acid, propyl gallate, epicatechin, epigallocatechin, and epigallocatechin gallate protect, rescue and, most importantly, restore the impaired movement activity (i.e., climbing capability) induced by paraquat in Drosophila melanogaster, a valid model of PD. We also showed for the first time that high concentrations of iron (e.g. 15 mM FeSO(4)) are able to diminish fly survival and movement to a similar extent as (20 mM) paraquat treatment. Moreover, paraquat and iron synergistically affect both survival and locomotor function. Remarkably, propyl gallate and epigallocatechin gallate protected and maintained movement abilities in flies co-treated with paraquat and iron. Our findings indicate that pure polyphenols might be potent neuroprotective agents for the treatment of PD against stressful stimuli.
authors.affiliation: School of Medicine, Medical Research Institute, Neuroscience Research Group, University of Antioquia (UdeA), Calle 62 # 52-59, Building 1, Room 412, Medellin, Colombia. marlene.jimenez@neurociencias.udea.edu.co
authors.forename: M
authors.initials: M
authors.lastname: Jimenez-Del-Rio
authors.forename: C
authors.initials: C
authors.lastname: Guzman-Martinez
authors.forename: C
authors.initials: C
authors.lastname: Velez-Pardo
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D004195:Disease Models, Animal; D004331:Drosophila melanogaster; D005260:Female; D005290:Ferric Compounds / Q000633:toxicity*; D005419:Flavonoids / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects; D010269:Paraquat / Q000633:toxicity*; D010300:Parkinson Disease / Q000188:drug therapy; D010636:Phenols / Q000494:pharmacology*; D059808:Polyphenols; D015996:Survival Rate
chemical_list: D000975:Antioxidants; D005290:Ferric Compounds; D005419:Flavonoids; D018696:Neuroprotective Agents; D010636:Phenols; D059808:Polyphenols; C024823:ferric sulfate; D010269:Paraquat
references.citation: Life Sci. 2006 Mar 27;78(18):2073-80
references.pmid: 16445946
references.citation: Inorg Chem. 2008 Jul 21;47(14):6153-61
references.pmid: 18553907
references.citation: J Neurosci. 2007 Mar 7;27(10):2457-67
references.pmid: 17344383
references.citation: Genes Dev. 1987 Jul;1(5):510-20
references.pmid: 3119425
references.citation: J Nutr. 2003 Oct;133(10):3248S-3254S
references.pmid: 14519822
references.citation: Biosci Biotechnol Biochem. 1997 Feb;61(2):225-9
references.pmid: 9058958
references.citation: Eur J Pharmacol. 2006 Sep 1;545(1):51-64
references.pmid: 16904103
references.citation: Ann Ist Super Sanita. 2007;43(4):348-61
references.pmid: 18209268
references.citation: Neurology. 1997 Jun;48(6):1583-8
references.pmid: 9191770
references.citation: J Med Food. 2007 Mar;10(1):32-40
references.pmid: 17472464
references.citation: Nature. 2000 Mar 23;404(6776):394-8
references.pmid: 10746727
references.citation: J Neurosci. 2007 Jan 31;27(5):981-92
references.pmid: 17267552
references.citation: Biochem J. 2002 May 15;364(Pt 1):121-8
references.pmid: 11988084
references.citation: Neurosci Res. 2008 Aug;61(4):404-11
references.pmid: 18538428
references.citation: Talanta. 2007 Jan 15;71(1):230-5
references.pmid: 19071293
references.citation: NeuroRx. 2005 Jul;2(3):484-94
references.pmid: 16389312
references.citation: Top Magn Reson Imaging. 2006 Feb;17(1):5-17
references.pmid: 17179893
references.citation: Exp Neurol. 2009 Feb;215(2):358-67
references.pmid: 19084006
references.citation: J Neurosci. 2007 Aug 8;27(32):8563-70
references.pmid: 17687034
references.citation: Nat Clin Pract Neurol. 2008 Nov;4(11):600-9
references.pmid: 18978800
references.citation: Trends Pharmacol Sci. 2003 Jan;24(1):41-3
references.pmid: 12498730
references.citation: Food Chem Toxicol. 2003 Jun;41(6):753-8
references.pmid: 12738180
references.citation: FASEB J. 2005 May;19(7):807-9
references.pmid: 15738004
references.citation: Chin Med J (Engl). 2005 Aug 20;118(16):1357-61
references.pmid: 16157030
references.citation: J Agric Food Chem. 2005 Mar 23;53(6):1841-56
references.pmid: 15769103
references.citation: Pharmacol Ther. 2006 Dec;112(3):677-700
references.pmid: 16935347
references.citation: Ann N Y Acad Sci. 2008 Dec;1147:93-104
references.pmid: 19076434
references.citation: J Magn Reson Imaging. 2008 Nov;28(5):1061-7
references.pmid: 18972346
references.citation: Neurotoxicology. 2006 Dec;27(6):1110-22
references.pmid: 16815551
references.citation: J Neurosci. 2004 Dec 1;24(48):10993-8
references.pmid: 15574749
references.citation: Toxicology. 2002 Aug 1;177(1):91-104
references.pmid: 12126798
references.citation: J Neurosci Res. 1993 May 1;35(1):67-82
references.pmid: 7685399
references.citation: Mol Nutr Food Res. 2007 May;51(5):546-54
references.pmid: 17440995
references.citation: Neurology. 2007 May 22;68(21):1820-5
references.pmid: 17515544
references.citation: Biochim Biophys Acta. 1973 Sep 26;314(3):372-81
references.pmid: 4751237
references.citation: J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
references.pmid: 8786384
references.citation: Brain Res. 2007 Jun 25;1155:196-207
references.pmid: 17493592
references.citation: Environ Toxicol. 2008 Feb;23(1):77-83
references.pmid: 18214927
references.citation: Neurochem Res. 2007 Oct;32(10):1646-54
references.pmid: 17468954
references.citation: Occup Environ Med. 2007 Oct;64(10):666-72
references.pmid: 17332139
references.citation: Annu Rev Entomol. 2002;47:535-59
references.pmid: 11729084
references.citation: J Neurochem. 1991 Dec;57(6):2133-5
references.pmid: 1940919
references.citation: J Neurosci. 2007 Jun 27;27(26):6914-22
references.pmid: 17596439
references.citation: J Biol Chem. 2008 Jan 25;283(4):1786-98
references.pmid: 18039652
references.citation: Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S35-8
references.pmid: 19131041
references.citation: Biochem Pharmacol. 2008 Sep 1;76(5):569-81
references.pmid: 18555207
references.citation: Behav Genet. 2002 Mar;32(2):89-94
references.pmid: 12036114
references.citation: Free Radic Biol Med. 2005 Dec 15;39(12):1591-600
references.pmid: 16298684
references.citation: Exp Neurol. 1994 Nov;130(1):82-94
references.pmid: 7529713
references.citation: Cell Biochem Biophys. 2009;53(2):75-100
references.pmid: 19184542
references.citation: J Pharmacol Exp Ther. 2002 Jan;300(1):91-6
references.pmid: 11752102
references.citation: Am J Ind Med. 1990;17(3):349-55
references.pmid: 2305814
references.citation: Neurology. 1985 Jul;35(7):949-56
references.pmid: 3874373